206A — PRISM Biolab Co Cashflow Statement
0.000.00%
Last trade - 00:00- ¥10bn
- ¥6bn
- ¥306m
Annual cashflow statement for PRISM Biolab Co, fiscal year end - September 30th, JPY millions except per share, conversion factor applied.
2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Yuho |
| Standards: | JAS | JAS | JAS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | 74.2 | -526 | -1,048 |
| Depreciation | |||
| Non-Cash Items | -4.6 | 27.9 | 268 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 32.2 | -24.8 | 930 |
| Change in Accounts Receivable | |||
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Taxes Payable | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | 103 | -514 | 150 |
| Capital Expenditures | -5.72 | -34.6 | -212 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | -2.16 | -5.79 | -32.5 |
| Sale of Fixed Assets | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -7.87 | -40.4 | -244 |
| Financing Cash Flow Items | — | — | -20.8 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 111 | — | 3,370 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 216 | -554 | 3,258 |